Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Milestone Pharmaceuticals Inc increased its cash reserves by 80.20%, or 6.12m. Cash Flow from Financing totalled 47.79m or 4,779.20% of revenues. In addition the company used 46.42m for operations while cash from investing totalled 4.76m.
Cash flow per share | -0.9549 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6003 |
---|---|
Tangible book value per share | 0.6003 |
More ▼
Balance sheet in USDView more
Current ratio | 19.13 |
---|---|
Quick ratio | -- |
Total debt/total equity | 1.61 |
---|---|
Total debt/total capital | 0.6171 |
More ▼